Literature DB >> 34185295

Endometrial Tumour Microenvironment.

Carlos Casas-Arozamena1, Miguel Abal2,3.   

Abstract

Endometrial cancer (EC) is the most common gynaecological tumour in developed countries, and its incidence is increasing in part due to the prevalence of obesity and its related hormone dysregulation. As described in this chapter, the tumour microenvironment plays a principal role in unopposed oestrogen stimulation promoting tumour cell proliferation. Factors and cytokines secreted by the different cell types defining the reactive tumour stroma also determine the invasive abilities of the tumour cells. Cancer-associated fibroblasts and tumour-associated macrophages actively participate through SDF-1, TGF-b or HGF to promote epithelial-to-mesenchymal transition or to generate an appropriate tumour niche. Likewise, endothelial cells facilitate lymph node and vascular infiltration through VEGF. Finally, the possibility to balance the immunosuppressive phenotypes in advanced endometrial cancer through the tumour microenvironment will probably represent a main therapeutic strategy in the near future.

Entities:  

Keywords:  Activated stroma; Carcinoma-associated fibroblasts; Endometrial cancer; Endothelial cells; Epithelial-mesenchymal transition; Extracellular matrix; Hormone-regulated tissue; Immune checkpoint inhibitors; Myometrial invasion; Oestrogen receptors; Pericytes; Tumour microenvironment; Tumour-associated macrophages; Tumour-derived growth factors; Tumour-infiltrating lymphocytes

Mesh:

Substances:

Year:  2020        PMID: 34185295     DOI: 10.1007/978-3-030-59038-3_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  45 in total

Review 1.  Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human.

Authors:  P G Groothuis; H H N M Dassen; A Romano; C Punyadeera
Journal:  Hum Reprod Update       Date:  2007 Jul-Aug       Impact factor: 15.610

Review 2.  New perspectives on screening and early detection of endometrial cancer.

Authors:  Laura Costas; Jon Frias-Gomez; Magdalena Guardiola; Yolanda Benavente; Marta Pineda; Miquel Á Pavón; José M Martínez; Maite Climent; Marc Barahona; Júlia Canet; Sonia Paytubi; Mónica Salinas; Luis Palomero; Ilaria Bianchi; Jaume Reventós; Gabriel Capellà; Mireia Diaz; August Vidal; Josep M Piulats; Álvaro Aytés; Jordi Ponce; Joan Brunet; Francesc X Bosch; Xavier Matias-Guiu; Laia Alemany; Silvia de Sanjosé
Journal:  Int J Cancer       Date:  2019-06-28       Impact factor: 7.396

Review 3.  The Ovarian Cycle.

Authors:  JoAnne S Richards
Journal:  Vitam Horm       Date:  2018-02-23       Impact factor: 3.421

Review 4.  Diagnosis and Management of Endometrial Cancer.

Authors:  Michael M Braun; Erika A Overbeek-Wager; Robert J Grumbo
Journal:  Am Fam Physician       Date:  2016-03-15       Impact factor: 3.292

Review 5.  Estrogen and cancer.

Authors:  Jing Liang; Yongfeng Shang
Journal:  Annu Rev Physiol       Date:  2012-10-08       Impact factor: 19.318

Review 6.  Atypical Endometrial Polyps and Concurrent Endometrial Cancer: A Systematic Review.

Authors:  Simone R de Rijk; Marlie E Steenbergen; Theodoor E Nieboer; Sjors F Coppus
Journal:  Obstet Gynecol       Date:  2016-09       Impact factor: 7.661

7.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

Authors:  N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa
Journal:  Ann Oncol       Date:  2015-12-02       Impact factor: 32.976

Review 8.  Genetics of endometrial cancer.

Authors:  Ayelet Shai; Yakir Segev; Steven A Narod
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

Review 9.  Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.

Authors:  Adriana C Rodriguez; Zannel Blanchard; Kathryn A Maurer; Jason Gertz
Journal:  Horm Cancer       Date:  2019-02-02       Impact factor: 3.869

10.  Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.

Authors:  J V Lacey; O B Ioffe; B M Ronnett; B B Rush; D A Richesson; N Chatterjee; B Langholz; A G Glass; M E Sherman
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.